Australian REITS Stock News

In late April 2026, Mesoblast Limited reported it had completed patient recruitment for its pivotal 300-patient Phase 3 trial of rexlemestrocel-L in chronic low back pain due to degenerative disc disease, a placebo-controlled study designed around a 12-month pain reduction endpoint and supported by the therapy’s RMAT designation. This milestone moves rexlemestrocel-L closer to potential FDA submission for a condition affecting over 7 million Americans and heavily tied to opioid use,...

DroneShield (ASX:DRO) is back in focus after a sector wide lift in defence names, as governments increase spending on counter drone capabilities and the company heads into its Q1 2026 results and earnings call. See our latest analysis for DroneShield. DroneShield’s recent pullback, with a 30 day share price return of 9.3% and a 7 day decline of 3%, sits against a stronger 90 day share price return of 8.7% and a very large 1 year total shareholder return of 173.5%. This suggests longer term...

Codan recently issued a major earnings upgrade and FY26 trading update, indicating FY26 EBIT is expected to be more than 60% higher than FY25 and that its Communications segment has reached a 30% profit margin target earlier than previously guided. This simultaneous outperformance in both defence-focused communications and Minelab’s metal detection products suggests Codan’s diversified technology portfolio is currently converting sector demand into higher-than-expected profitability. We’ll...

Mineral Resources recently reported a strong Q3 FY26 update, lifting production guidance across iron ore, lithium and mining services, while also completing a US$1.30 billion dual-tranche bond refinancing and securing a US$765 million lithium joint venture deal with Posco Holdings. The sharp recovery in lithium pricing has turned a previously weaker division back into a key profit contributor just as the company strengthens its balance sheet and brings in a global battery-materials...

In recent months CSL has announced workforce reductions, plasma centre closures and delays to the planned Seqirus influenza vaccine spin-off, alongside guidance cuts and ongoing margin pressures that have unsettled investors. This combination of restructuring, margin compression and Seqirus revenue challenges has prompted a reassessment of how durable CSL’s core plasma and vaccine franchises may be. We’ll now examine how margin pressures and the delayed Seqirus spin-off reshape CSL’s...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

In April 2026, APA Group completed a A$1.50 billion debt raise, including A$1.00 billion in hybrid subordinated capital securities and A$500 million in 6.42% senior unsecured notes due 2036, to support its stated growth plans. The strong investor demand for these fixed-income securities, with the issuances reportedly nearly four times oversubscribed, underlines fixed-income appetite for APA’s income-focused infrastructure profile. Now we’ll consider how this heavily oversubscribed A$1.50...

Suncorp Group Limited recently completed a Fixed-Income Offering, issuing A$200 million of Floating Rate Hybrid Notes that are convertible, non-cumulative and subordinated, with a variable coupon structure. This hybrid issuance adds a new layer to Suncorp’s capital structure, blending debt and equity characteristics that may influence how investors assess its funding mix and risk profile. We’ll now examine how Suncorp’s use of subordinated, floating rate hybrid capital could reshape its...

Recent share performance and fundamentals Greatland Resources (ASX:GGP) has drawn attention after a recent uptick in share price over the past month, alongside a year to date return above 25%, prompting investors to reassess the A$9.1b miner. The company reports revenue of A$1,918.1m and net income of A$645.1m, with revenue growth of 4.7% and net income movement showing a 5.0% decline on an annual basis. See our latest analysis for Greatland Resources. At a latest share price of A$13.5,...

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

In late April 2026, Telix Pharmaceuticals reported Phase 2 OPTIMAL-PSMA dosimetry data for its second-generation prostate cancer candidate TLX597-Tx, showing low radiation uptake in non-target organs and supporting further evaluation in earlier-stage disease, while also progressing a Regeneron collaboration and a European review of its glioma imaging agent TLX101-Px. These developments highlight how Telix is trying to build an integrated radiopharmaceutical platform, pairing next-generation...

With the business potentially at an important milestone, we thought we'd take a closer look at 6K Additive, Inc.'s...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Potential Tartana Minerals Limited ( ASX:TAT ) shareholders may wish to note that the Independent Non-Executive...

Cochlear Limited recently downgraded its FY26 net profit guidance from A$435–A$460 million to A$290–A$330 million, citing softer demand, delayed surgeries, and geopolitical disruptions in key markets. This setback has drawn attention to how dependent Cochlear’s earnings are on procedure volumes and hospital capacity, despite its strong competitive position in implantable hearing solutions. We’ll now examine how this earnings guidance cut, driven by weaker demand and delayed surgeries, may...

In late April 2026, Nickel Industries Limited reported its March quarter results, delivering record adjusted EBITDA of US$135.6 million, supported by a higher Indonesian production quota, accelerated ore sales, and progress on the Excelsior Nickel Cobalt project. Alongside this financial performance, the company highlighted a lost time injury frequency rate of 0.00, expanded conservation efforts over about 197 hectares of primary forest at Hengjaya, and a stronger liquidity position through...

This article walks step by step through whether BHP Group at around A$54.94 may be offering fair value, a stretch price, or a potential opportunity. The stock has seen a 4.5% return over the last 30 days and a 20.1% return year to date, while the 1 year return sits at 50.3% and the 5 year return at 73.5%, so recent price action is firmly on investors' radar. Recent coverage has focused on BHP Group's role as a major materials player, with attention on how global demand for resources and...

On 29 April 2026, Ramelius Resources reported its most profitable quarter to date, delivering a very large all-in sustaining cost margin despite revising cost guidance higher due partly to accounting changes and stronger gold prices. At the same time, the company accelerated its share buyback and advanced high‑grade discoveries at Dalgaranga, underlining management’s conviction in the business while industry‑wide diesel cost pressures continued to reshape its operating cost base. We’ll now...

Evolution Mining (ASX:EVN) has reported a significant uplift in its gold and copper resources, linked to recent exploration results and ongoing expansion studies. This has drawn fresh attention to the miner’s long term production profile. See our latest analysis for Evolution Mining. Despite the fresh resource update, Evolution Mining’s recent share price momentum has cooled, with a 30 day share price return of a 10.99% decline and a 90 day share price return of a 17.40% decline. This comes...

NEXTDC Limited recently completed a large-scale capital raising, including an A$750 million subordinated floating rate wholesale notes issue and an approximately A$1.51 billion rights-based follow-on equity offering, as part of its previously announced A$2.20 billion capital plan. These transactions lift NEXTDC’s pro forma liquidity to about A$6.60 billion and broaden its funding base as it pursues growth in Australia’s expanding data centre market. We’ll now examine how this expanded A$6.60...

BofA Securities has initiated coverage of Life360 (ASX:360). The firm highlights expectations for user growth, new offerings such as elderly and pet trackers, and deeper integration partnerships in the family safety app market. See our latest analysis for Life360. Life360’s A$20.0 share price comes after a year-to-date share price return decline of 38.39%, while the 3-year total shareholder return of about 3x suggests longer term holders have still seen very large gains. This may indicate...

Why Arafura Rare Earths’ Upcoming Earnings Call Matters Arafura Rare Earths (ASX:ARU) is set to hold its Q3 2026 earnings call on 29 April. Many investors are watching the event closely for fresh detail on project progress, funding, and outlook. See our latest analysis for Arafura Rare Earths. At a share price of A$0.36, Arafura Rare Earths has seen strong recent momentum, with a 30 day share price return of 18.03%, a 90 day share price return of 56.52%, and a 1 year total shareholder return...

Board refresh draws fresh attention to Aurelia Metals Aurelia Metals (ASX:AMI) has attracted fresh interest after announcing that Franklyn (Lyn) Brazil will rejoin its Board as a Non Executive Director, representing Brazil Farming Pty Ltd. Brazil brings prior Aurelia board experience, a background in agriculture and philanthropy, and a history of investing in ASX listed companies. Accounting and markets professional Bradley Newcombe will act as his alternate director. See our latest analysis...

South32 Limited recently reported its March 2026 quarter and year-to-date production, alongside confirming most FY26 production guidance but cutting Australia Manganese output guidance by 6% due to elevated site water levels and recent severe weather impacts. The company also scheduled a special call to update investors on its Hermosa project, underscoring the growing importance of this US growth asset within South32’s portfolio. We’ll now examine how the revised Australian Manganese...